LAPTM4B Promotes Autophagy through Regulation of ATG3 in Hepatocellular Carcinoma by 王菲
 
 
学校编码：10384                                分类号密级 







LAPTM4B Promotes Autophagy through Regulation of 
ATG3 in Hepatocellular Carcinoma 
王 菲 
指导教师姓名：尹震宇 教授 
专 业  名 称：微 生 物 学   
论文提交日期：2017年  月 
论文答辩时间：2017年  月 





























































































































































（     ）1.经厦门大学保密委员会审查核定的保密学位论文，于   
年  月  日解密，解密后适用上述授权。 







                             声明人（签名）： 





















































































 Hepatocellular carcinoma (HCC) is one of the most common malignances 
with high morbidity and mortality worldwide. There are not obvious symptoms in the 
early stage of HCC. Although advancement of the diagnosis and treatment of HCC have 
been made, the overall survival rate of patients with HCC remains poor. Therefore, it is 
urgently needed to identify novel therapeutic targets. 
Autophagy play crucial role in the turmorgenesis and development of cancers. 
It has been reported that autophagy can regulate the growth, metastasis and energy 
metabolism of HCC. LAPTM4B (Lysosomal Transmembrane Protein 4 beta) exerts 
oncogenic activity in tumors, such as promoting cell proliferation, migration, invasion 
and inhibition of cell apoptosis. LAPTM4B also induce anthracycline intracellular 
retention, reduce injury drugs on DNA, and affect the stability of the lysosomal 
membrane. Recent studies demonstrated that LAPTM4B is involved in cell autophagy. 
However, the underlying molecular mechanisms by which LAPTM4B regulates 
autophagy remain elucidated.  
Methods and results 
1.We performed qPCR to detect the expression of LAPTM4B in 60 pairs of 
liver cancer samples and found that the expression level of LAPTM4B was significantly 
higher in tumor tissues than that in paired nontumor tissues. 
2.We performed gain- and loss-of-function assays to investigate the effect of 
LAPTM4B on the proliferation of HCC cells. The results showed that LAPTM4B 
significantly promoted cell proliferation both in vivo and in vitro. 
3. The effects of LAPTM4B on autophagy in HCC cells were detected by 
western blot and immunofluorescence assay. The results showed that LAPTM4B could 
increase starvation-induced autophagy. 
4. qPCR and western blot assays were used to detect the ATGs expression 
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LAPTM4B could affect the expression of ATG3 (autophagy related protein). Moreover, 
the expression of LAPTM4B was positively correlated with ATG3 in tumor tissues. 
5. LAPTM4B promotes autophagy through regulation of ATG3 in HCC. 
Silence of ATG3 abolished the promotion of autophagy induced by LAPTM4B 
upregulation, whereas overexpression of ATG3 rescued autophagy inhibition mediated 
by LAPTM4B silence. 
Conclusion 
LAPTM4B can not only increase the cell proliferation in HCC, but also 
induce autophagy of HCC. LAPTM4B promotes autophagy in an ATG3-dependent 
manner in HCC. 
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英文缩略表 
英文缩写 英文全名 中文全名 
HCC Hepatocellular Carcinoma 肝细胞癌（肝癌） 
LAPTM4B Lysosomal Transmembrane Protein 4 beta 溶酶体跨膜蛋白 4β 
ATG3 Autophagy related protein-3 自噬相关蛋白 
PCR polymerase chain reaction 聚合酶链反应 
RT-PCR reverse transeription polymerase chain reaction 逆转录聚合酶链反应 
qPCR real time fluorescence quantitative PCR 实时荧光定量聚合酶链
反应 
DNA deoxyribonucleic acid 脱氧核糖核酸 
dsDNA double-stranded DNA 双链 DNA 
RNA ribonucleic acid 核糖核酸 
mRNA Messager Ribonucleic acid 信使 RNA 
dNTP deoxyribonucleoside triphosphate 脱氧核糖三磷酸 
E.coli Escherichia coli 大肠杆菌 
cDNA complement deoxyribonucleic acid 互补脱氧核糖核酸 
shRNA short hairpin RNA 短发夹 RNA 
RNase A Robonuclease A 核糖核酸酶 A 
DMEM Dulbecco’s Modified Eagle Media DMEM细胞培养基 
PBS Phosphate Buffered Saline 磷酸盐缓冲液 
PVDF polyvinylidene fluoride 聚偏二氟乙烯膜 
SSC saline sodium citrate 柠檬酸钠缓冲液 
TAE Tris-acetate-EDTA 三羟甲基氨基甲烷-冰乙
酸-乙二胺四乙酸 
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TBST Tris-Buffered Saline and Tween 20 TBST洗膜液 
HBV 
AFP 
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明在肝癌患者中约 30%的患者具有慢性肝病史约，且 HbsAg 阳性者的数量占到
一半以上。因此乙型肝炎病毒和丙型肝炎病毒是肝癌发生的主要病因。台湾一项
有 11800多名研究对象的具有前瞻性的研究表明，在排除年龄、性别等的影响因
素后，和 HBsAg与 HBeAg均阴性的人相比，仅 HBsAg的阳性者患肝细胞癌的
相对危险度大约为 9.6( 95%CI:6.0~15.2)，然而 HBsAg 和 HBeAg 均为阳性的人
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感染产生协同作用，增加了患肝癌的风险。启东研究表明，即便是中等程度暴露
于黄曲霉毒素下，也会使 HBV的感染者得肝癌的风险增加 2倍[11]。AFB1 -8，9-
环氧化物也可以攻击蛋白质，形成 AFB1白蛋白加合物(AFB1 –albumin adducts，
AFB1 ALB)而残留在血液中，其主要形式为 AFB1 赖氨酸加合物(AFB1 lysine)，尿




的 AFB1 甲酰胺加合物(aflatoxinB1formamidopyrimidineadduct, AFB1 -FAPY)。暴露
于 AFB1 几周内后 AFB1 -FAPY 可升到最高浓度，并且可在体内持续较长时间。
AFB1 -N7 -GUA具有 AP位点的加合物、AFB1 -FAPY可能是 AFB1在体内发挥毒
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